20 insiders reported 105 Form 4 transactions for ROCKET PHARMACEUTICALS, INC. (RCKT) over the past 18 months (most recent 2026-09-15). Recent activity: Wilson Martin (General Counsel) Sell 75,364 shares, Wilson Martin (General Counsel) Sell 631 shares, Shah Gaurav (CEO) Sell 2,293 shares, Wilson Martin (General Counsel) Sell 3,493 shares, Shah Gaurav (CEO) Sell 2,837 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Wilson Martin | General Counsel | Sell | 75,364 | $256,464 |
| 2026-08-20 | Wilson Martin | General Counsel | Sell | 631 | $2,133 |
| 2026-08-20 | Shah Gaurav | CEO | Sell | 2,293 | $7,753 |
| 2026-08-17 | Wilson Martin | General Counsel | Sell | 3,493 | $11,810 |
| 2026-08-17 | Shah Gaurav | CEO | Sell | 2,837 | $9,592 |
| 2026-08-13 | Chaudhuri Sarbani | Chief Commercial & Medical Affairs Officer | Sell | 4,701 | $16,449 |
| 2026-08-13 | Stevens Christopher James | Chief Operating Officer | Sell | 36,658 | $128,266 |
| 2026-08-05 | SOUTHWELL DAVID P | Director | Buy | 150,000 | $0 |
| 2026-08-05 | Stevens Christopher James | Chief Operating Officer | Buy | 73,313 | $0 |
| 2026-07-06 | WONG RODERICK | Director | Buy | 27,832 | $0 |
| 2026-07-06 | BOESS CARSTEN | Director | Buy | 22,862 | $0 |
| 2026-07-06 | Dolsten Mikael | Director | Buy | 22,862 | $0 |
| 2026-07-06 | SOUTHWELL DAVID P | Director | Buy | 22,862 | $0 |
| 2026-07-06 | Malik Fady Ibraham | Director | Buy | 22,862 | $0 |
| 2026-07-06 | Fong Peter | Director | Buy | 22,862 | $0 |
| 2026-05-26 | Shah Gaurav | CEO | Buy | 76,490 | $129,268 |
| 2026-05-26 | Shah Gaurav | CEO | Sell | 55,684 | $172,064 |
| 2026-05-21 | Militello John | Vice President of Finance, Treasurer, Principal Accounting Officer | Sell | 384 | $1,156 |
| 2026-05-21 | Shah Gaurav | CEO | Sell | 2,409 | $7,251 |
| 2026-05-21 | Wilson Martin | General Counsel | Sell | 662 | $1,993 |
| 2026-05-14 | Wilson Martin | General Counsel | Sell | 3,361 | $12,133 |
| 2026-05-14 | Shah Gaurav | CEO | Sell | 2,728 | $9,848 |
| 2026-05-14 | Militello John | Vice President of Finance, Treasurer, Principal Accounting Officer | Sell | 855 | $3,087 |
| 2026-05-11 | Chaudhuri Sarbani | Chief Commercial & Medical Affairs Officer | Sell | 17,650 | $67,776 |
| 2026-02-20 | Militello John | Vice President of Finance, Treasurer, Principal Accounting Officer | Sell | 1,157 | $3,864 |
Source: SEC Form 4 filings · as of 2026-09-15